These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 22960458)

  • 1. Behavioral effects of chronic methamphetamine treatment in HIV-1 gp120 transgenic mice.
    Henry BL; Geyer MA; Buell M; Perry W; Young JW; Minassian A;
    Behav Brain Res; 2013 Jan; 236(1):210-220. PubMed ID: 22960458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prepulse inhibition in HIV-1 gp120 transgenic mice after withdrawal from chronic methamphetamine.
    Henry BL; Geyer MA; Buell MR; Perry W; Young JW; Minassian A;
    Behav Pharmacol; 2014 Feb; 25(1):12-22. PubMed ID: 24281153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of methamphetamine and HIV-1 gp120 causes distinct long-term alterations of behavior, gene expression, and injury in the central nervous system.
    Hoefer MM; Sanchez AB; Maung R; de Rozieres CM; Catalan IC; Dowling CC; Thaney VE; Piña-Crespo J; Zhang D; Roberts AJ; Kaul M
    Exp Neurol; 2015 Jan; 263():221-34. PubMed ID: 25246228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of HIV gp120 protein increases sensitivity to the rewarding properties of methamphetamine in mice.
    Kesby JP; Hubbard DT; Markou A; Semenova S
    Addict Biol; 2014 Jul; 19(4):593-605. PubMed ID: 23252824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of Methamphetamine-induced stereotypic behaviour in transgenic mice expressing HIV-1 envelope protein gp120.
    Roberts AJ; Maung R; Sejbuk NE; Ake C; Kaul M
    J Neurosci Methods; 2010 Feb; 186(2):222-5. PubMed ID: 19917310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methamphetamine Exposure Combined with HIV-1 Disease or gp120 Expression: Comparison of Learning and Executive Functions in Humans and Mice.
    Kesby JP; Heaton RK; Young JW; Umlauf A; Woods SP; Letendre SL; Markou A; Grant I; Semenova S
    Neuropsychopharmacology; 2015 Jul; 40(8):1899-909. PubMed ID: 25652249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methamphetamine-induced behavioral sensitization is enhanced in the HIV-1 transgenic rat.
    Liu X; Chang L; Vigorito M; Kass M; Li H; Chang SL
    J Neuroimmune Pharmacol; 2009 Sep; 4(3):309-16. PubMed ID: 19444617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive deficits associated with combined HIV gp120 expression and chronic methamphetamine exposure in mice.
    Kesby JP; Markou A; Semenova S;
    Eur Neuropsychopharmacol; 2015 Jan; 25(1):141-50. PubMed ID: 25476577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methamphetamine-induced behavioral and physiological effects in adolescent and adult HIV-1 transgenic rats.
    Kass MD; Liu X; Vigorito M; Chang L; Chang SL
    J Neuroimmune Pharmacol; 2010 Dec; 5(4):566-73. PubMed ID: 20532992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological and behavioral effects of methamphetamine in a mouse model of endotoxemia: a preliminary study.
    Sánchez-Alavez M; Gombart LM; Huitrón-Reséndiz S; Carr JR; Wills DN; Berg G; Campbell IL; Gauvin DV; Henriksen SJ; Criado JR
    Pharmacol Biochem Behav; 2004 Feb; 77(2):365-70. PubMed ID: 14751466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modafinil improves methamphetamine-induced object recognition deficits and restores prefrontal cortex ERK signaling in mice.
    González B; Raineri M; Cadet JL; García-Rill E; Urbano FJ; Bisagno V
    Neuropharmacology; 2014 Dec; 87():188-97. PubMed ID: 24530829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methamphetamine augment HIV-1 Tat mediated memory deficits by altering the expression of synaptic proteins and neurotrophic factors.
    Nookala AR; Schwartz DC; Chaudhari NS; Glazyrin A; Stephens EB; Berman NEJ; Kumar A
    Brain Behav Immun; 2018 Jul; 71():37-51. PubMed ID: 29729322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge.
    Segal DS; Kuczenski R; O'Neil ML; Melega WP; Cho AK
    Neuropsychopharmacology; 2003 Oct; 28(10):1730-40. PubMed ID: 12865898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficits in behavioral sensitization and dopaminergic responses to methamphetamine in adenylyl cyclase 1/8-deficient mice.
    Bosse KE; Charlton JL; Susick LL; Newman B; Eagle AL; Mathews TA; Perrine SA; Conti AC
    J Neurochem; 2015 Dec; 135(6):1218-31. PubMed ID: 26146906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of environmental enrichment during induction of methamphetamine dependence on the behavioral withdrawal symptoms in rats.
    Hajheidari S; Miladi-Gorji H; Bigdeli I
    Neurosci Lett; 2015 Sep; 605():39-43. PubMed ID: 26275348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling human methamphetamine exposure in nonhuman primates: chronic dosing in the rhesus macaque leads to behavioral and physiological abnormalities.
    Madden LJ; Flynn CT; Zandonatti MA; May M; Parsons LH; Katner SN; Henriksen SJ; Fox HS
    Neuropsychopharmacology; 2005 Feb; 30(2):350-9. PubMed ID: 15483561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methamphetamine-induced locomotor activity and behavioral sensitization: are dopamine d3 receptors involved?
    Jones CD; Bartee JA; Leite-Browning ML; Blackshear MA
    Cell Mol Biol (Noisy-le-grand); 2007 May; 53(4):15-22. PubMed ID: 17531156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge.
    O'Neil ML; Kuczenski R; Segal DS; Cho AK; Lacan G; Melega WP
    Synapse; 2006 Nov; 60(6):465-73. PubMed ID: 16897726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained attention and vigilance deficits associated with HIV and a history of methamphetamine dependence.
    Pocuca N; Young JW; MacQueen DA; Letendre S; Heaton RK; Geyer MA; Perry W; Grant I; Minassian A;
    Drug Alcohol Depend; 2020 Oct; 215():108245. PubMed ID: 32871507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Region-specific changes in markers of neuroplasticity revealed in HIV-1 transgenic rats by low-dose methamphetamine.
    Ohene-Nyako M; Persons AL; Napier TC
    Brain Struct Funct; 2018 Sep; 223(7):3503-3513. PubMed ID: 29931627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.